Global X Management Company’s Halozyme HALO Stock Holding History

Global X Management Company’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$33K	Sell	1,932 -518	-21%	-$9.79K	﹤0.01%	1157
2018 Q1	$48K	Buy	2,450 +614	+33%	+$11.9K	﹤0.01%	1024
2017 Q4	$37K	Buy	1,836 +415	+29%	+$7.63K	﹤0.01%	957
2017 Q3	$25K	Buy	1,421 +204	+17%	+$2.76K	﹤0.01%	1025
2017 Q2	$16K	Buy	1,217 +812	+200%	+$10.8K	﹤0.01%	1184
2017 Q1	$5K	Buy	405 +25	+7%	+$316	﹤0.01%	1177
2016 Q4	$4K	Hold	380	–	–	﹤0.01%	1070
2016 Q3	$5K	Hold	380	–	–	﹤0.01%	1063
2016 Q2	$3K	Buy	+380	New	+$3.75K	﹤0.01%	972
2014 Q3	–	Sell	-2,779	Closed	-$27K	–	542
2014 Q2	$27K	Buy	2,779 +1,264	+83%	+$10.7K	﹤0.01%	411
2014 Q1	$19K	Buy	+1,515	New	+$22.5K	﹤0.01%	507

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Global X Management Company's HALO Position: Q2 2018 in Review

Global X Management Company reduced its Halozyme (HALO) stake by 21% in Q2 2018, selling an estimated $9.79K and leaving 1,932 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1157.

Global X Management Company first reported a position in HALO in Q1 2014 and has held it in 11 quarters since. The position peaked at $48K in Q1 2018. 193 funds tracked by Wall St. Rank hold HALO as of Q2 2018.

Global X Management Company held 1,932 shares of Halozyme worth $33K as of Q2 2018.
Global X Management Company sold 518 Halozyme shares in Q2 2018, an estimated $9.79K.
Halozyme made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1157 holding.
Global X Management Company first reported a position in Halozyme in Q1 2014 and has held it in 11 quarters since.
Global X Management Company's Halozyme position peaked at $48K in Q1 2018.
193 funds tracked by Wall St. Rank held Halozyme as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.